A detailed history of Great West Life Assurance CO transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 72,784 shares of PCRX stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,784
Previous 47,958 51.77%
Holding current value
$1.26 Million
Previous $1.37 Million 20.06%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$11.7 - $28.46 $290,464 - $706,547
24,826 Added 51.77%
72,784 $1.1 Million
Q2 2024

Aug 12, 2024

BUY
$25.5 - $31.51 $222,589 - $275,050
8,729 Added 22.25%
47,958 $1.37 Million
Q1 2024

May 13, 2024

BUY
$27.7 - $35.48 $68,003 - $87,103
2,455 Added 6.68%
39,229 $1.15 Million
Q4 2023

Feb 13, 2024

SELL
$26.32 - $34.31 $222,904 - $290,571
-8,469 Reduced 18.72%
36,774 $1.24 Million
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $162,481 - $212,316
5,296 Added 13.26%
45,243 $1.39 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $47.5 $427,841 - $562,637
-11,845 Reduced 22.87%
39,947 $1.6 Million
Q1 2023

May 12, 2023

BUY
$35.53 - $43.38 $178,538 - $217,984
5,025 Added 10.74%
51,792 $2.11 Million
Q4 2022

Feb 10, 2023

SELL
$38.19 - $57.45 $138,706 - $208,658
-3,632 Reduced 7.21%
46,767 $1.81 Million
Q3 2022

Nov 01, 2022

BUY
$51.24 - $58.89 $292,068 - $335,673
5,700 Added 12.75%
50,399 $2.68 Million
Q2 2022

Aug 12, 2022

BUY
$51.49 - $81.64 $2.3 Million - $3.65 Million
44,699 New
44,699 $2.61 Million
Q2 2022

Aug 09, 2022

SELL
$51.49 - $81.64 $1.98 Million - $3.14 Million
-38,506 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$60.03 - $76.49 $8,764 - $11,167
146 Added 0.38%
38,506 $3.02 Million
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $25,040 - $32,473
522 Added 1.38%
38,360 $2.3 Million
Q2 2021

Aug 11, 2021

BUY
$59.18 - $69.99 $4,379 - $5,179
74 Added 0.2%
37,838 $2.3 Million
Q1 2021

May 17, 2021

SELL
$59.31 - $78.82 $262,090 - $348,305
-4,419 Reduced 10.48%
37,764 $2.65 Million
Q4 2020

Feb 16, 2021

SELL
$50.47 - $66.26 $240,741 - $316,060
-4,770 Reduced 10.16%
42,183 $2.52 Million
Q3 2020

Nov 17, 2020

BUY
$51.97 - $63.0 $2.42 Million - $2.93 Million
46,504 Added 10357.24%
46,953 $2.82 Million
Q3 2020

Nov 13, 2020

SELL
$51.97 - $63.0 $2.63 Million - $3.19 Million
-50,568 Reduced 99.12%
449 $26,000
Q2 2020

Aug 17, 2020

SELL
$30.8 - $52.47 $120,551 - $205,367
-3,914 Reduced 7.13%
51,017 $2.67 Million
Q1 2020

May 14, 2020

BUY
$28.4 - $50.7 $120,387 - $214,917
4,239 Added 8.36%
54,931 $1.84 Million
Q4 2019

Feb 11, 2020

BUY
$36.31 - $46.83 $1.84 Million - $2.37 Million
50,692 New
50,692 $2.3 Million
Q3 2019

Oct 25, 2019

SELL
$35.66 - $44.99 $132,262 - $166,867
-3,709 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$36.57 - $47.97 $60,523 - $79,390
-1,655 Reduced 30.85%
3,709 $0
Q4 2018

Feb 12, 2019

BUY
$41.31 - $52.16 $63,162 - $79,752
1,529 Added 39.87%
5,364 $222,000
Q3 2017

Nov 09, 2017

BUY
$35.7 - $39.5 $136,909 - $151,482
3,835
3,835 $148,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $796M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.